Institutional Ownership Acrivon Therapeutics, Inc. (ACRV)
This table provides information about the institutional ownership of Acrivon Therapeutics, Inc. (ACRV). We have compiled data on the 54 institutions that hold shares in the stock, with a total of 18.5 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2025 Q2 2025 |
8,340,508
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Sands Capital Ventures, LLC
Arlington, VA |
Aug 13, 2025 Q2 2025 |
2,122,605
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 28.44%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,895,519
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 10.57%
|
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
888,130
shares
|
$0
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
767,020
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 3.11%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
593,247
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 12.08%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
509,295
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 877.53%
|
|
|
Acorn Capital Advisors, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
405,237
shares
|
$0
0.32% of portfolio
|
Q4 2024
New holding
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Aug 14, 2025 Q2 2025 |
382,234
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
311,829
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
296,239
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Health Cor Management, L.P.
New York, NY |
Feb 14, 2023 Q4 2022 |
284,201
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
181,187
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 59.77%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
181,172
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
164,362
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 46.31%
|
|
|
Squarepoint Ops LLC
New York, NY |
Aug 27, 2025 Q2 2025 |
152,605
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Hrt Financial LP
New York, NY |
Aug 14, 2025 Q2 2025 |
145,895
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
140,055
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 143.49%
|
|
|
Xtx Topco LTD
London, X0 |
Aug 12, 2025 Q2 2025 |
106,119
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
67,145
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 71.13%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
63,636
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 42.84%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
63,016
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 78.92%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
46,776
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 57.1%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
43,860
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 200.82%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
32,600
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|